Optimize Lab Operations with a Unified Platform

By David

In today’s competitive environment, Life Sciences organizations need to optimize operations by improving efficiency while maximizing quality and adhering to regulations. The drug development process can be expensive, slow and risky.

According to Tufts Center for the Study of Drug Development, the cost to develop and win marketing approval for a new drug is $2.6 Billion and takes more than 10 years to bring to market.

In addition, pharmaceutical companies face major challenges including patent expirations, increased FDA inspections, as well as increasing competition in the global marketplace and decreasing margins. In order to contribute to corporate directives, laboratories also need to remove inefficiencies and compliance risks from processes as well as provide a collaborative environment that fosters innovation.

In any industry, the best way to be successful is by doing the right project and by doing projects right. This means that scientific processes for product R&D as well as Quality and Operations must be aligned with business goals, requiring visibility across the enterprise. Organizational silos, which hinder business efficiency and agility, must be eliminated and, instead, integrated through a single information hub.

onelab-jul15-ls-mobile-320x149

Single Solution for a Unified Laboratory:

The Dassault Systèmes ONE Lab industry solution experience integrates people, resources, processes, and data, providing interfaces from research, development, and quality labs on a single platform. It is designed to address today’s market challenges by improving operational excellence through collaboration that shortens time to market.

Integration Hub Based on One Foundation:

ONE Lab works as an integration hub for BIOVIA and third-party applications and instruments. It allows seamless data transfer between the different domains from research to manufacturing, as well as with external collaborators and integrates lab processes like resource or data lifecycles based on a common foundation.

Standardized Approach:

ONE Lab provides a standardized approach for all laboratory processes including the usage of lab equipment, materials and procedures. It also addresses the management of procedures, recipes, and resources and handles the execution of lab workflows. This allows the lab to increase efficiency by eliminating paper and manual processes, and improve process knowledge through visualization and analytics.

Role-based User Experience:

ONE Lab speaks in the language of each user, offering a unified role-based user experience for all scientists and managers involved in the laboratory process.  Users can develop and execute methods, recipes and processes with domain-specific templates configured to deliver the appropriate information for each particular role.

Digital Lab Experience:

Through shared access to digital information, One Lab helps eliminate disconnected and paper-based processes that tend to be error-prone. Compliance is improved through templates, standard work practices and rapid reporting with all information aggregated and standardized from one source.

Knowledge Capture:

The ONE Lab solution connects lab-to-plant workflows and information across the product lifecycle from ideation to commercialization supporting research, product development and production. Through Knowledge Management, Life Sciences companies can improve operational excellence and collaboration and shorten time to market.

Access and sharing of common, relevant data throughout the research, development and manufacturing lifecycle is key in reducing research, development and production times, identifying non-promising product potentials sooner in the process, optimizing the drug development process and accelerating the product release while maintaining quality. This requires collaboration from inception through product commercialization that is reliant upon a single data foundation.  To learn more, download the solution brief.

Optimize Your Therapeutics Production Process

By David

The life sciences industry is the driving force behind major medical breakthroughs and therapies that ensure public health. The sustainability of a competitive, innovative biopharmaceutical sector depends on collaboration across enterprise to overcome bottlenecks and address key challenges.

Pharmaceutical companies typically are linked to a complex network of other organizations requiring partners adapt to meet changing regulatory compliance, as well as manage collaboration. In order to master the complex relationships that exist between process development, manufacturing, and quality operations as well as outsourced operations, companies must learn to flawlessly execute processes, leverage internal and external knowledge, conform to regulatory agencies and minimize risk while simultaneously facing pressure to reduce costs.

To meet these challenges, manufacturers need a business framework that integrates all areas of the extended enterprise so that every unit can leverage the same information. Additionally, real-time visibility into manufacturing and process data will provide the insight needed to understand critical process parameters so that manufacturers can quickly adapt operations for continuous improvement.

Dassault Systèmes’ Made to Cure for BioPharma provides a collaborative environment that helps speed time-to-market and maximize profitability. This solution enables pre-emptive action by providing visibility into process operations, quality and compliance risks, helping to optimize product quality as well as the production process of therapeutics.

madetocurebiopharma-ls-mobile-320x149

Data Driven Insights for Business Improvement

Process development, manufacturing and quality functions generate an abundance of data, which needs to be presented in a user-friendly, organized form to be leveraged. Made to Cure for BioPharma provides all key stakeholders with self-service, on-demand access to process and quality data from disparate databases and paper records from one location helping users to gain process knowledge and improve production operations.

The access to timely and reliable analyses and reports helps support business as well as compliance requirements. The automatic aggregation and contextualization of the data delivers near real-time insight into operations enabling companies to quickly identify, understand, monitor and improve process and product variability. Data can be reused and shared across global operations internally and externally, thereby quickly spreading insights and knowledge to improve decision making.

Optimize Performance for Improved Profitability

Therapeutics manufacturing can be costly and ineffective management of regulatory actions can lead to additional filings costing both time and money. Poor tech transfer from lab to in-house and outsourced operations can result in inadequate therapeutics process design that failed to learn from prior experience. A collaborative validated business framework can help reduce operational disruptions that occur with disconnected systems and units that can lead to regulatory recalls that could potentially damage the brand in the marketplace.

By  easily aggregating and contextualizing data and providing role-based visibility of critical production process and product parameters, Dassault Systèmes’ Made to Cure for BioPharma can shorten process development times, enable tech transfer , and bring quality products to market with lower risk and improved profitability. To learn more, download the solution brief.

Extending the Showroom Experience Into the Home With BDHOME

By Akio

BD-Home

BDHOME, a leading omnichannel retailer of innovative and affordable home decor in China, and Dassault Systèmes announced at the Kitchen & Bath China 2015 expo in Shanghai that they are partnering to revolutionize the home decoration industry in greater China with unique consumer experiences that extend beyond the showroom and into the home.

To support this initiative, the two companies will create a joint venture that will accelerate the adoption of Dassault Systèmes’ 3DEXPERIENCE platform by the home furniture and decoration markets.

The joint venture combines the expertise of Dassault Systèmes in transformative digital solutions and of BDHOME in creative business models for high-quality, affordable home decor, to provide powerful 3D technologies that bring a new level of quality to the showroom experience.

Specifically, the joint venture will distribute Dassault Systèmes’ 3DVIA brand of applications for smart, 3D space planning solutions in mainland China, Hong Kong, Macau and Taiwan.

It will develop related 3D content, services and experiences for furniture manufacturers such as virtual furniture and catalogues targeting furniture customization, construction and decorating materials.

Consumers can use the 3DVIA HomeByMe online interior design application to visualize and customize ideas for home decor or remodeling projects in 3D, and bring showrooms into their homes for a personalized decorating experience.

Click to TweetClick to Tweet: #HomeByMe helps Chinese consumers
visualize & customize ideas for home decor & remodeling in #3D

“With increasing demands for personal consumption from Chinese consumers, ‘customer experience’ has become a priority for each furniture manufacturer and retailer in terms of product production and sales,” said Mr. Chen Zaochun, President, BDHOME.

“Dassault Systèmes’ 3DVIA provides 3D virtual space, numerous decoration catalogues and fashion-tracking styles so that Chinese consumers can use their imaginations to build a home that belongs to them, and enjoy the amazing experience of decorating it. As the competition in the furniture market grows even fiercer, through its partnership with Dassault Systèmes, a global leader in 3D technology, BDHOME hopes to offer core competitiveness to furniture manufacturers while fostering better values for customers through the development of excellent customer experience.”

“Home design holds a very special place in Chinese culture—where a long history of ancestral tradition in furniture manufacturing blends art, customs and know-how—and, together with BDHOME, our ambition is to help designers and consumers reveal and unleash their creativity by combining a traditional approach to home and office decoration with the new standards of today’s society,” said Bernard Charlès, President & CEO, Dassault Systèmes.

Click to TweetClick to Tweet: “Home #design holds a very special place
in Chinese culture.” -@BernardCharles

“We look forward to replicating the European success of our 3DVIA HomeByMe application in greater China with a specialized partner like BDHOME, whose online-offline business model and rigorous selection of international designers have created a paradigm shift in the region’s traditional home decor retail channels. The power of the virtual world has already been successfully demonstrated in multiple industries. Together with BDHOME we can complement and support existing businesses in the home decoration industry with customer-centric, value-added services that virtually unite the consumer, designer and retailer.”

Click to TweetClick to Tweet: “Power of #virtual has been proven in multiple industries,
now entering China’s home decor market.” -@BernardCharles

About BDHOME

As founded by nine veteran designers in China, BDHOME is a leading interior soft decoration solutions provider that markets total soft decoration and imported home supplies in OTO model.

More than 13,000 kinds of products are provided by BDHOME, mainly in neo-classic, neo-oriental, neo-US and modern styles.

Now BDHOME has set up offline experience stores in more than 20 cities in China and the onsite designers will provide total design solutions and recommendations to consumers without charge. For more information, visit www.BDHOME.cn.

Related Resources

Collaborative and Industrialized Construction from Dassault Systèmes



Page 3 of 23912345...102030...Last »